| Application no. and date | 20865925.0 (espacenet) (Federated) (European Patent Register), 20200918 | | Patent/reg. no. and date | DK/EP 4031133, 20250813 | | Publication date | 20220727 | | Priority no. and date | WO PCT/US2019/052024, 20190919, US 201916576360, 20190919, US 201962902887 P, 20190919, US 201916576720, 20190919, US 201962906437 P, 20190926, US 202063024441 P, 20200513, US 202063024432 P, 20200513, US 202062704785 P, 20200528, US 202062705106 P, 20200611 | | EP pub. no. and date |
EP 4031133 20220727 | | Effective date | | | Applicant/owner | Novo Nordisk Health Care AG,
The Circle 32/38
8058 Zürich, CH | | Applicant ref. no. | | | Inventor | BABU, Suresh, c/o Forma Therapeutics, Inc. 500 Arsenal Street,
Suite 100
Watertown, MA 02472, US,
SHETH, Pratik,
Watertown, 02472, US,
TALADI, Vijay,
Somerset, 08873, US,
MITCHELL MINIKIS, Ryan,
Somerset, 08873, US | | Representative | | | Opponent | | | IPC Class | A61K 31/407 (2006.01) , A61K 31/436 (2006.01) , A61K 9/00 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61P 7/06 (2006.01) , C07D 487/04 (2006.01) , C07D 519/00 (2006.01) | | Title | PYRUVATE KINASE R (PKR) ACTIVATING COMPOSITIONS | | Int. application no. | US2020051645 | | Int. publication no. | WO2021055863 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
